trt with retatrutide Tirzepatide and Testosterone Together: Safety and Considerations trt and retatrutide What to

Patients begin to lose weight, often seeing steady, sustainable fat reduction. Increased satiety and appetite regulation, helping control food intake. Improved insulin sensitivity, reducing the need for additional diabetes medications

Therapy should be initiated and monitored only by qualified healthcare professionals

Treatment should be discontinued if inadequate response occurs: less than 5% weight loss after 6 months for Wegovy or 12 weeks for Saxenda at maintenance doses

Waiting ensures: More predictable, longer-lasting results Reduced risk of needing revision surgery due to ongoing weight changes Most patients are advised to maintain a stable weight for several months before proceeding with body contouring, facial surgery, or breast procedures

Caloric restriction alone often fails because insulin dysfunction prevents efficient fat mobilization

PMID 12529935